CLMT

CLMT

USD

Calumet Inc. Common Stock

$14.170+0.250 (1.796%)

实时价格

基础材料
特种化学品
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$13.920

最高价

$14.300

最低价

$13.810

成交量

1.02M

公司基本面

市值

1.2B

所属行业

特种化学品

国家/地区

United States

交易统计

平均成交量

1.12M

交易所

NMS

货币

USD

52周价格范围

最低价 $7.68当前价 $14.170最高价 $25.29

AI分析报告

最后更新: 2025年6月7日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

CLMT (Calumet Inc. Common Stock): Decoding Recent Signals & Future Paths

Stock Symbol: CLMT Generate Date: 2025-06-07 15:48:19

Let's break down what's been happening with Calumet and what the tea leaves might be telling us. This company, Calumet Inc., is in the Specialty Chemicals business, making all sorts of specialized products and even getting into renewable fuels. They've got about 1620 full-time employees, and their market cap sits around $1.16 billion.

Recent News Buzz: What's the Vibe?

The news flow for Calumet has been a bit of a mixed bag, but leans slightly positive overall.

First, there's news from May 23rd about Calumet planning to attend a couple of investor conferences in June. This is generally a good sign. When a company goes out to meet investors, it often means they're looking to share positive updates, attract new capital, or simply boost their profile. It suggests they're actively engaging with the market, which can build confidence.

Then, we have Wells Fargo's take from May 14th. Analyst Roger Read kept an "Overweight" rating on Calumet, which is a bullish signal – essentially saying they expect the stock to perform better than the market average. However, he did trim the price target from $23 down to $21. So, while the sentiment remains positive, the lowered target indicates a slight tempering of expectations on how high the stock might go in the near term. It's not a red flag, but it's something to note.

Putting it together, the news suggests a company that's still seen favorably by analysts and is actively trying to connect with investors.

Price Check: What's the Stock Been Doing?

Looking at the last few months, Calumet's stock has seen quite a ride. Back in early March, it was hovering around $12-$13. It then had a pretty sharp dip in early April, falling below $9, before starting a steady climb back up.

More recently, from mid-April through late May, the stock showed a nice upward trend, moving from the $9-$10 range up to around $14. This indicates some solid buying interest building up.

As of June 6th, the stock closed at $13.44. This is a bit off its recent highs in late May (around $14.60), suggesting a slight pullback or consolidation after that strong run. The trading volume on June 6th was also quite low at 464,700 shares, well below its average volume of 1,169,742. Lower volume on a slight dip can sometimes indicate that the selling pressure isn't particularly strong.

Now, for the AI's crystal ball:

  • Today's Prediction: A slight dip of -0.26%.
  • Next Day's Prediction: A notable jump of +1.62%.
  • The Day After Next: A modest gain of +0.35%.

The AI seems to be predicting a short-term bounce after a minor dip, suggesting a continuation of the generally positive trend seen in May.

Outlook & Ideas: Putting It All Together

Given the news, the recent price action, and the AI's short-term outlook, the situation for CLMT appears to lean towards a "hold" with potential for "accumulate" on dips.

Here's the thinking:

  • News Sentiment: The "Overweight" rating from Wells Fargo, even with a lowered price target, is still a vote of confidence. The investor conferences are also a positive signal.
  • Price Action: The stock has shown resilience, bouncing back strongly from its April lows and establishing a clear uptrend through May. The recent slight pullback could be a healthy consolidation.
  • AI Prediction: The AI's forecast of a bounce over the next couple of days aligns with the idea that any current weakness might be temporary. The AI also projects an upward trend with a potential target price of $17.32, which is significantly higher than the current price.

Potential Entry Consideration: If you're looking to get in, the current price around $13.44 or a slight dip towards the $13.38-$13.47 range (as suggested by the recommendation data) could be interesting. This area seems to be holding as a support level after the recent run-up. The AI's prediction of a slight dip today followed by gains might present a small window.

Potential Exit/Stop-Loss Consideration:

  • Taking Profits: The recommendation data suggests a take-profit level around $14.39. This aligns with the stock's recent highs and could be a reasonable target if the upward momentum resumes. The AI's longer-term target of $17.32 offers a more ambitious goal, but it's wise to consider shorter-term profit-taking points.
  • Managing Risk (Stop-Loss): To protect against unexpected downturns, a stop-loss order below a recent support level, perhaps around $12.08 (as per the recommendation data), would make sense. If the stock falls below this point, it could signal a breakdown of the recent uptrend.

Company Context: What Else to Know

Remember, Calumet is a specialty chemicals company that's also moving into renewable fuels. This dual focus is important. While specialty chemicals can be a stable business, the renewable fuels segment could offer significant growth potential, especially with increasing global focus on sustainability. This diversification might make the company more resilient to market shifts. Their P/E ratio is negative (-192.0x), which isn't unusual for companies investing heavily in growth areas or those with fluctuating earnings, but it means traditional valuation metrics need careful interpretation.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.

相关新闻

PR Newswire

Calumet to Participate in June 2025 Investor Conferences

Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that it plans to attend two investor conferences in June 2025. On Thursday, June 5th,...

查看更多
Calumet to Participate in June 2025 Investor Conferences
Analyst Upgrades

Wells Fargo Maintains Overweight on Calumet, Lowers Price Target to $21

Wells Fargo analyst Roger Read maintains Calumet with a Overweight and lowers the price target from $23 to $21.

查看更多
Wells Fargo Maintains Overweight on Calumet, Lowers Price Target to $21

AI预测Beta

AI建议

看涨

更新于: 2025年6月13日 02:00

看跌中性看涨

66.0% 置信度

风险与交易

风险等级3/5
中风险
适合于
价值
交易指南

入场点

$13.98

止盈点

$15.28

止损点

$12.76

关键因素

PDI 16.1高于MDI 8.4,且ADX 15.2,表明看涨趋势
当前价格接近支撑水平$13.96,表明有潜在的买入机会
交易量是平均值的6.1倍(10,330),表明极强的买入压力
MACD 0.0206高于信号线0.0066,表明看涨交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。